|
At the Ocular Surface Center, Dr. Tseng
has obtained a special license from State of Florida to compound
the following medications to augment the therapeutic effects
of treating complex and difficult ocular surface diseases.
Dr. Tseng can prescribe and compound these medications ONLY
to the patient seen by him.
- Autologous Serum Drops
For
more information, click to download the PDF file.
For Stevens Johnson Syndrome (TEN), the severe
dryness, irritation and squamous metaplasia can be helped
by this medication [See Fig.
19]
- Non-preserved Steroid Drops
For complex and inflammatory ocular surface diseases, especially
those with Delayed Tear Clearance [See Fig.
32], non-preserved methylprednisolone
or dexamethasone
eye drops
help break the vicious cycle prior created and improve
patient's comfort [See Fig.
33,
Fig.34 and Fig.
35]
- Lipid Lubricant Ointment
When lipid tear deficiency dry eye is diagnosed by Kinetic
Analysis of Tear Interference Images, such shown in
this patient suffering from Stevens Johnson syndrome (TENS),
application of Lipid Lubricant Ointment results in comfort
and improvement of the lipid film in tears [See Fig.
36].
- Retinoic Acid Ointment
When there
is focal keratinization on the lid margin or the bulbar
conjunctiva, application of 0.01% retinoic acid ointment
is useful.
- Mitomycin Drops
Topical 0.04% mitomycin
eye drops are useful to treat different forms of conjunctival
and corneal neoplasms
|
|
 |
|
- Tseng SCG, Maumenee AE, Stark
WJ, Maumenee IH, Jensen Ad, Green WR, Kenyon KR. Topical
retinoid treatment for various dry-eye disorders. Ophthalmology
92:717-727,
1985.
- Espana EM, Chodosh J, Mateo AJ,
Di Pascuale MA, Tseng SCG. Retinoides Topicos como Tratamiento
no Invasivo de la Neoplasia Intraepithelial Conjuntival.
Microcirugia Ocular 11:169-174. 2003.
- Di Pascuale, Espana
EM, Tseng SCG. A case of conjunctival-cornea intraepithelial
neoplasia successfully treated with topical mitomycin c
and interferon α2B in cycles. Cornea
23:89-92, 2004.
|
